Samanvaya Healthcare Profile
Key Indicators
- Authorised Capital ₹ 4.30 Cr
as on 29-12-2024
- Paid Up Capital ₹ 3.60 Cr
as on 29-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.80 Cr
as on 29-12-2024
- Satisfied Charges ₹ 3.00 M
as on 29-12-2024
- Revenue 7.33%
(FY 2021)
- Profit -1011.61%
(FY 2021)
- Ebitda -79.29%
(FY 2021)
- Net Worth -21.30%
(FY 2021)
- Total Assets -1.87%
(FY 2021)
About Samanvaya Healthcare
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.30 Cr and a paid-up capital of Rs 3.60 Cr.
The company currently has active open charges totaling ₹5.80 Cr. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Dharana and Shilpa Kanthi serve as directors at the Company.
- CIN/LLPIN
U85110KA2011PTC057965
- Company No.
057965
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Gadag, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Samanvaya Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Dharana  | Director | 01-Apr-2011 | Current |
| Shilpa Kanthi | Additional Director | 10-Jul-2024 | Current |
Financial Performance of Samanvaya Healthcare.
Samanvaya Healthcare Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 7.33% increase. The company also saw a substantial fall in profitability, with a 1011.61% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samanvaya Healthcare?
In 2021, Samanvaya Healthcare had a promoter holding of 71.95% and a public holding of 28.05%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Syndicate Bank Creation Date: 07 Sep 2015 | ₹1.30 Cr | Open |
Syndicate Bank Creation Date: 11 May 2012 | ₹4.50 Cr | Open |
Syndicate Bank Creation Date: 25 Oct 2013 | ₹3.00 M | Satisfied |
How Many Employees Work at Samanvaya Healthcare?
Samanvaya Healthcare has a workforce of 18 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samanvaya Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samanvaya Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
